Gene · 57721
Papers4,298
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,461 to 1,480 of 4,298
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Roles of m6A modification in oral cancer (Review). | Int J Oncol | 2023 | 36382642 | PubTator, text mining | PubMed |
| Methyltransferase-like 3 promotes cervical cancer metastasis by enhancing cathepsin L mRNA stability in an N6-methyladenosine-dependent manner. | Cancer Sci | 2023 | 36382580 | PubTator, text mining | PubMed |
| Promotive role of USP29-mediated deubiquitination in malignant proliferation of colorectal cancer cells via the KIAA1429/SOX8 axis. | Biomol Biomed | 2023 | 36373629 | PubTator, text mining | PubMed |
| Fusobacterium nucleatum stimulates cell proliferation and promotes PD-L1 expression via IFIT1-related signal in colorectal cancer. | Neoplasia | 2023 | 36371909 | PubTator, text mining | PubMed |
| m6A readers, writers, erasers, and the m6A epitranscriptome in breast cancer. | J Mol Endocrinol | 2023 | 36367225 | PubTator, text mining | PubMed |
| Role of N6‑methyladenosine in the pathogenesis, diagnosis and treatment of pancreatic cancer (Review). | Int J Oncol | 2023 | 36367195 | PubTator, text mining | PubMed |
| Aberrant elevation of FTO levels promotes liver steatosis by decreasing the m6A methylation and increasing the stability of SREBF1 and ChREBP mRNAs. | J Mol Cell Biol | 2023 | 36352530 | PubTator, text mining | PubMed |
| EpiFactors 2022: expansion and enhancement of a curated database of human epigenetic factors and complexes. | Nucleic Acids Res | 2023 | 36350659 | PubTator, text mining | PubMed |
| Probing the dynamic RNA structurome and its functions. | Nat Rev Genet | 2023 | 36348050 | PubTator, text mining | PubMed |
| METTL3 promotes colorectal cancer metastasis by promoting the maturation of pri-microRNA-196b. | J Cancer Res Clin Oncol | 2023 | 36348020 | PubTator, text mining | PubMed |
| N6-methyladenosine-related lncRNAs in combination with computational histopathology and radiomics predict the prognosis of bladder cancer. | Transl Oncol | 2023 | 36327698 | PubTator, text mining | PubMed |
| FTO inhibits oxidative stress by mediating m6A demethylation of Nrf2 to alleviate cerebral ischemia/reperfusion injury. | J Physiol Biochem | 2023 | 36327034 | PubTator, text mining | PubMed |
| Transcriptome-wide N6-methyladenosine modification profiling of mRNAs during infection of Newcastle disease virus in chicken macrophages. | Virus Res | 2023 | 36326508 | PubTator, text mining | PubMed |
| Research progress of m6A methylation in prostate cancer. | Asian J Androl | 2023 | 36308073 | PubTator, text mining | PubMed |
| N6-methyladenosine demethylase FTO enhances chemo-resistance in colorectal cancer through SIVA1-mediated apoptosis. | Mol Ther | 2023 | 36307991 | PubTator, text mining | PubMed |
| Quantitative sequencing using BID-seq uncovers abundant pseudouridines in mammalian mRNA at base resolution. | Nat Biotechnol | 2023 | 36302989 | PubTator, text mining | PubMed |
| Downregulation of the m6A reader protein YTHDC1 leads to islet β-cell failure and diabetes. | Metabolism | 2023 | 36302453 | PubTator, text mining | PubMed |
| RM2Target: a comprehensive database for targets of writers, erasers and readers of RNA modifications. | Nucleic Acids Res | 2023 | 36300630 | PubTator, text mining | PubMed |
| Function and prognostic value of N6-methyladenosine-modified RNAs in lung adenocarcinoma. | J Gene Med | 2023 | 36282144 | PubTator, text mining | PubMed |
| Identification of a novel prognostic signature correlated with epithelial-mesenchymal transition, N6-methyladenosine modification, and immune infiltration in colorectal cancer. | Cancer Med | 2023 | 36281556 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/57721/papers?page=74